Cargando…
Evaluation of a new immunoassay for chromogranin A measurement on the Kryptor system
BACKGROUND: Chromogranin A (CgA) is a biomarker for neuroendocrine tumors (NETs). The aims of this study were to evaluate differences in measurement between the ThermoFisher Brahms CgA Kryptor assay and the CisBio assay and to investigate the influence of patient covariates. Temperature stability of...
Autores principales: | van der Knaap, R.H.P., Kwekkeboom, D.J., Ramakers, C.R.B., de Rijke, Y.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597707/ https://www.ncbi.nlm.nih.gov/pubmed/28932793 http://dx.doi.org/10.1016/j.plabm.2015.03.002 |
Ejemplares similares
-
Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement
por: Choi, Yu Jeong, et al.
Publicado: (2021) -
Comparison of Procalcitonin Assays on KRYPTOR and LIAISON(®) XL Analyzers
por: Dipalo, Mariella, et al.
Publicado: (2019) -
Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit
por: Kim, Mijin, et al.
Publicado: (2016) -
Chromogranins can be measured in samples from cats and dogs
por: Stridsberg, Mats, et al.
Publicado: (2014) -
Decision Threshold for Kryptor sFlt‐1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting
por: Andersen, Lise Lotte Torvin, et al.
Publicado: (2021)